1. Patients with abdominal aortic aneurysms have reduced levels of microRNA 122-5p in circulating exosomes
- Author
-
Jose L. Lopez, Joel L. Ramirez, Tuan Anh Phu, Phat Duong, Laura Bouchareychas, Christina R. Kuhrau, Pei-Yu Lin, Walter L. Eckalbar, Andrea J. Barczak, Joshua D. Rudolph, Lenka Maliskova, Michael S. Conte, Shant M. Vartanian, Robert L. Raffai, Adam Z. Oskowitz, and Subramanian, Venkateswaran
- Subjects
screening and diagnosis ,Multidisciplinary ,General Science & Technology ,Exosomes ,Real-Time Polymerase Chain Reaction ,Cardiovascular ,Aortic Aneurysm ,4.1 Discovery and preclinical testing of markers and technologies ,MicroRNAs ,Detection ,Rare Diseases ,Clinical Research ,Genetics ,Humans ,Biomedical Imaging ,2.1 Biological and endogenous factors ,Abdominal ,Aetiology ,Biomarkers ,Biotechnology ,4.2 Evaluation of markers and technologies - Abstract
Objective There are currently no specific biomarkers to identify patients with abdominal aortic aneurysms (AAAs). Circulating exosomes contain microRNAs (miRNA) that are potential biomarkers for the presence of disease. This study aimed to characterize the exosomal miRNA expression profile of patients with AAAs in order to identify novel biomarkers of disease. Methods Patients undergoing duplex ultrasound (US) or computed tomography (CT) for screening or surveillance of an AAA were screened to participate in the study. Cases with AAA were defined as having a max aortic diameter >3 cm. Circulating plasma exosomes were isolated using Cushioned-Density Gradient Ultracentrifugation and total RNA was extracted. Next Generation Sequencing was performed on the Illumina HiSeq4000 SE50. Differential miRNA expression analysis was performed using DESeq2 software with a Benjamini-Hochberg correction. MicroRNA expression profiles were validated by Quantitative Real-Time PCR. Results A total of 109 patients were screened to participate in the study. Eleven patients with AAA and 15 non-aneurysmal controls met study criteria and were enrolled. Ultrasound measured aortic diameter was significantly larger in the AAA group (mean maximum diameter 4.3 vs 2.0 cm, P = 6.45x10-6). More AAA patients had coronary artery disease (5/11 vs 1/15, P = 0.05) as compared to controls, but the groups did not differ significantly in the rates of peripheral arterial disease and chronic obstructive pulmonary disease. A total of 40 miRNAs were differentially expressed (PP = 1.8x10-5; FDR P = 0.02). Conclusion Plasma exosomes from AAA patients have significantly reduced levels of miRNA-122-5p compared to controls. This is a novel exosome-associated miRNA that warrants further investigation to determine its use as a diagnostic biomarker and potential implications in AAA pathogenesis.
- Published
- 2023